Literature DB >> 17060921

Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations.

A Zhang1, Q Xing, S Qin, J Du, L Wang, L Yu, X Li, L Xu, M Xu, G Feng, L He.   

Abstract

Variants within the human UGT1A1 gene are associated with irinotecan induced severely adverse reactions and hyperbilirubinemia. Intra-ethnic differences in the genetic variation and haplotypes of UGT1A1 gene have been analyzed in the present study. Relationship between the concentrations of total serum bilirubin (T-bil) and haplotype structure of UGT1A1 in healthy people were also evaluated. We genotyped five functional polymorphisms including -3279T>G and -3156G>A in the enhancer region, (TA)6>7 in the TATA box, and 211G>A (G71R), 686C>A (P229Q) in the exon1 region of UGT1A1 in three groups of healthy Chinese ethnic populations, consisting of 264 subjects of She origin, 539 of Han origin and 273 of Dong origin. The distribution of -3279T>G, (TA)6>7, 211G>A of UGT1A1 differed greatly as between the three ethnic groups. All of six haplotypes differed considerably between at least two of the three groups, which highlighted the need to analyze clinically irinotecan toxicity relevant SNPs and haplotypes in a variety of different racial groups within the Chinese population. Total bilirubin concentration in homozygous carriers of the -3279G and (TA)7 allele were significantly higher than those in heterozygous carriers or homozygous carriers of wild-type alleles. Carriers of the variant haplotypes (-3279G; -3156A; (TA)7; 211G; 686C) had higher serum T-Bil concentrations compared with the other groups. Our results indicate that heterogeneity among different ethnic populations is possibly the result of microevolution and is relevant to studies into the effect of tailored drug treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060921     DOI: 10.1038/sj.tpj.6500424

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  18 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

Review 2.  Systemic therapies for pancreatic cancer--the role of pharmacogenetics.

Authors:  Ross A Soo; Wei-Peng Yong; Federico Innocenti
Journal:  Curr Drug Targets       Date:  2012-06       Impact factor: 3.465

3.  [UGT1A1 gene mutations in Chinese Dong neonates in Sanjiang, Guangxi].

Authors:  Xuan Yao; Dan-Ni Zhong; Yun-Cong Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-07-15

4.  UGT1A1 gene polymorphism: impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer.

Authors:  Christoph Schulz; Volker Heinemann; Andreas Schalhorn; Nikolas Moosmann; Thomas Zwingers; Stefan Boeck; Clemens Giessen; Hans-Joachim Stemmler
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

5.  Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling.

Authors:  Zoe E Barter; Geoffrey T Tucker; Karen Rowland-Yeo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

6.  Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study.

Authors:  Takumi Kawaguchi; Atsumasa Komori; Masataka Seike; Shigetoshi Fujiyama; Hiroshi Watanabe; Masatoshi Tanaka; Shotaro Sakisaka; Makoto Nakamuta; Yutaka Sasaki; Makoto Oketani; Toshihiro Hattori; Koichi Katsura; Michio Sata
Journal:  J Gastroenterol       Date:  2012-06-08       Impact factor: 7.527

Review 7.  The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions.

Authors:  Sara Correia Marques; Ogechi N Ikediobi
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

8.  Genetic variants and haplotypes of the UGT1A9, 1A7 and 1A1 genes in Chinese Han.

Authors:  Xiaoqing Zhang; Guokun Ao; Yuewen Wang; Wei Yan; Min Wang; Erfei Chen; Fangfang Yang; Jin Yang
Journal:  Genet Mol Biol       Date:  2012-05-24       Impact factor: 1.771

9.  Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai.

Authors:  Xun Cai; Weiguo Cao; Honghua Ding; Tianshu Liu; Xinli Zhou; Mei Wang; Ming Zhong; Ziyi Zhao; Qing Xu; Liwei Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-28       Impact factor: 4.553

Review 10.  The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.

Authors:  Fazal-I-Akbar Danish; Saeeda Yasmin
Journal:  Hepat Med       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.